GORDON, ERLINDA M. et al
"A Phase I/II Investigation of Safety and Efficacy of Nivolumab and nab-Sirolimus in Patients With a Variety of Tumors With Genetic Mutations in the mTOR Pathway." Anticancer Research
43.5
(2023):
1993-2002.
Web. 18 April. 2024.